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The Meniscus Deficient 




The preservation of the structure of the meniscus despite a tear has been widely 
discussed in the literature. However, meniscectomy continues to be the most-
performed meniscus surgery. In a percentage of patients, knee pain and swelling, 
as well as tibial plateau bony edema, follow meniscus resection; this panoply of 
symptoms is known as “post-meniscectomy syndrome”. The management of this 
condition requires meniscus transplant in case of total meniscectomy or a meniscus 
scaffold in the case of a partial resection. This chapter aims to discuss the indica-
tion, surgical technique, and outcomes of collagen meniscus implants (CMI) for 
partial resections and meniscus transplants for full resections.
Keywords: meniscus transplant, collagen meniscus implant, post-meniscectomy 
syndrome, meniscus scaffold, osteoarthritis
1. Introduction
It is essential to understand the anatomy and biomechanics of the knee joint 
before performing a sub-total or total meniscectomy due to the possible catastrophic 
consequences at a long-term follow-up. Moreover, the medial and the lateral com-
partment of the knee have different kinematic properties and the clinician must 
take into account the different degree of mobility, bony structure, and load distribu-
tion between these two compartments. Biomechanical studies have demonstrated 
the essential role of the menisci on load transfer, in that a total meniscectomy can 
increase the contact area by 33 to 50 percent in a fully extended knee [1].
Walker et al. demonstrated that the lateral compartment is much more depen-
dent on meniscal function than the medial one. The lateral meniscus carries a 
higher percentage of load transfer than the medial meniscus. This is due to a higher 
load being transferred directly by the exposed cartilage surface of the medial com-
partment [1]. The different bony morphology of the tibiofemoral compartments 
also play a part in this. In the sagittal plane, the medial convexity of the femoral 
condyle and the concavity of the tibial plateau provide a degree of congruity, even 
after a meniscectomy. While, on the lateral side, both the convexity of the femoral 
condyle and the lateral tibial plateau make this compartment much more prone to 
an increase in peak contact pressures after meniscectomy [2].
Clinically, the differences between the medial and lateral meniscus have been 
confirmed by worse results reported after lateral meniscectomy compared to medial 
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meniscectomy at a long-term follow-up [3, 4]. These findings are even more stark if the 
meniscectomy is performed during adolescence: in a prospective 30 years of follow-up 
study, about 80% of patients after medial meniscectomy maintained good or excellent 
clinical results; in comparison to less than 50% for lateral meniscectomy [5].
The causal relationship of knee arthritis with meniscectomy led to the investiga-
tion of meniscal allograft transplantation for the post-meniscectomy patient expe-
riencing pain and demonstrating arthritic changes [6]. Basic science studies have 
shown that although meniscal allografts cannot fully replicate the function of the 
native meniscus, the grafts are able to significantly improve joint contact area and 
decrease contact pressures [7, 8]. Also, early clinical series demonstrated isolated 
meniscal allograft transplantation to be a feasible procedure [9, 10]. However, the 
initial studies had variable outcomes due to significant differences in indications, 
surgical techniques, and tissue processing methods.
As experience was gained, the variables became more defined and the results 
improved. Numerous short and midterm studies have shown that meniscal 
allografts are able to provide pain relief and increase function with high rates of 
graft survivorship [11, 12]. More recently, a long-term study has been published 
demonstrating >50% graft survival at 20 years [13].
However, if a subtotal meniscectomy has previously been performed, a meniscal 
scaffold may be a more appropriate procedure, despite the relative lack of relevant 
articles with extended follow-up. There are two different scaffold types available on 
the market: the collagen meniscus implant (CMI) derived from a bovine collagen 
and the Actifit, a polyurethane scaffold [14, 15]. 3D printed scaffolds have been 
recently proposed as an experimental treatment and only a few case reports are 
available, while CMI and Actifit have been widely studied.
2. Biomechanics
After a meniscal tear, the effectiveness of meniscal repair strictly relies on the tissue 
quality and defect location with respect to the vascular supply. Tears in the vascular-
ized “red” peripheral zone are more likely to heal, while the more common lesions in 
the avascular “white” zone have poor healing potential [16, 17]. When the majority of 
the meniscus is not salvageable, a meniscectomy is usually performed. It has been well 
documented that meniscectomy increases the risk of degenerative joint disease of the 
knee. For example, Persson et al. demonstrated that in almost 2,500 patients followed 
for more than 20 years, the risk of developing arthritis after a partial meniscectomy 
was almost 6 times higher than the standard population, with a 17% absolute risk [18].
Structurally, it has been demonstrated that meniscal allografts should be frozen, not 
sterilized using chemicals or radiation. It the first published series of isolated menis-
cal allografts, Milakowski et al. found that graft processing methods were vital to the 
success of the procedure [19]. He reported that lyophilized grafts lead to inferior results 
compared to fresh frozen grafts. While clinical series have not shown benefit of cryo-
preserved over fresh frozen, basic science studies have shown slightly better mechanic 
properties with cryopreserved, with a higher elastic modulus and point of rupture [20].
While meniscus allograft transplantation appropriately addresses a prior total or 
subtotal meniscectomy, an allograft is not a solution for the treatment of a partial 
meniscus defect. The Collagen Meniscus Implant (Ivy Sports Medicine, Germany) 
is a porous biologic scaffold. It consists of 97% type I collagen purified from bovine 
Achilles tendon while the remaining portion is composed of glycosaminoglycan 
(GAG). The specific size of the scaffold’s micropores are controlled to increase the 
fibrocartilage maturation while avoiding pseudo-capsule formation and foreign 
body reaction [21].
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The second scaffold type consists of a synthetic polyurethane-based material 
composed of flexible segments made from polycaprolactone 80% and stiff segments 
made from urethane 20% (Actifit; Orteq Sports Medicine, London, UK). The scaffold 
slowly biodegrades, with an estimated decomposition time of 4 to 6 years. The implant 
itself is also highly porous to allow for sufficient ingrowth [22]. Both the Actifit and the 
CMI implants come in separate configurations for medial or lateral meniscus defects.
3. Surgical technique
The indications for both meniscus allograft and scaffold vary by surgeon, but in 
general, the patient should have previously undergone a total or partial meniscec-
tomy, respectively, and present with discomfort only in the compartment previ-
ously operated upon. Maximal osteoarthritis allowed is grade III and a minimum 
2 mm joint space. Also, if the knee is clinically unstable, it should be stabilized at 
the time of the procedure with respect to the anterior cruciate ligament. If operative 
knee alignment is more than 3–5 degrees different concerning the involved com-
partment compared to the contralateral knee, an osteotomy should be performed to 
unload the affected compartment.
For meniscus allograft transplant, the traditional methodology denotes the use 
of medial side double bone plugs, and a press-fit bone bridge (keyhole) method on 
the lateral side (Figure 1). On the medial side bone plugs are used due to graft size 
and anterior attachment variability, while on the lateral side bone bridges are used 
due to horn proximity [13]. In the case of a concomitant ACL and lateral meniscus, 
the femoral and tibial ACL tunnels are drilled initially and then the lateral meniscus 
trough is made. The femoral side of the ACL is then secured, followed by placement 
of the lateral meniscal allograft, and finally the tibial side of the ACL is secured. 
While a number of papers have investigated all-soft tissue constructs, several basic 
science studies have demonstrated improved biomechanical function with bony 
meniscal attachments [23, 24].
For meniscus scaffolds, surgical technique is similar for both devices. This 
begins with arthroscopic resection of the surrounding damaged tissue and subse-
quent implantation of a custom-sized scaffold. The sized scaffold is then sutured to 
the meniscal rim and capsule using standard techniques (Figure 2).
Figure 1. 
Lateral keyhole technique with suture fixation and medial bone plug technique with suture fixation.
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Initially, a partial meniscectomy is performed, with surgical debridement back 
to the vascularized zone of the damaged portion of the native meniscus. It is par-
ticularly important that the meniscal rim be continuous, especially at the popliteal 
hiatus of the lateral meniscus. If there is complete loss of the tissue in front of the 
popliteus tendon, it should be considered a total loss and thus a contraindication 
for a meniscus scaffold. After debridement, the resulting void is sized along the 
peripheral edge using the meniscal ruler supplied with the scaffold. The scaffold is 
then cut to fit, placed into the knee, and finally sutured to the native meniscus. The 
surgeon can use an all-inside, inside-out, or outside-in suture technique depending 
on the area to be sutured and their experience and preference [25].
4. Clinical outcomes
Early results showed meniscus transplant could be a viable procedure; however, 
the initial results were mixed and raised concerns of long-term durability. It the first 
series of isolated meniscal allografts, Milakowski et al. demonstrated that graft pro-
cessing methods were vital to the success of the procedure [9]. He reported the use 
of lyophilized grafts lead to inferior results compared to fresh frozen grafts. In the 
first American published series, Garrett et al. reported success in 35 of 43 patients 
(81%) at 2 to 7-year follow-up [26]. However, 6 of the 11 patients with grade IV 
chondromalacia failed, leading to the conclusion that while beneficial, grafts should 
not be placed in knees with advanced arthritis.
In the early experience of Noyes et al. they reported a high failure rate [27]. They 
evaluated 38 patients with 40 grafts, with a follow-up at an average of 40 months 
(24–62 months). While clinically the patients did significantly better, on MRI 30% 
of grafts demonstrated “altered characteristics” with another 28% demonstrating 
gross failure. Patients with no pre-operative arthritis demonstrated 10 abnormal 
MRIs out of 22, while the arthritic group showed abnormalities in 13 of 18, again 
demonstrating the folly of allograft implantation in arthritic knees.
Figure 2. 
Custom meniscal scaffold sizing and fixation.
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Over time, graft processing methods, patient selection parameters, and surgical 
techniques were refined. With these improvements, meniscus allograft transplant 
ceased being seen as experimental (Table 1) [28].
Numerous short and mid-term studies reported that the vast majority of 
the grafts did not require reoperation, and a significant number of patients had 
decreased pain and improved function [29–32]. In a large series, Verdonk et al. 
reported a survivorship of 79% in the first 100 patients at a mean of 7.2 years [33].
Kim et al. published the most optimistic longer-term data on meniscal allograft 
transplantation, with 2 failures in 49 knees after a minimum follow-up of 8 years. 
The 10-year survival rate was 98.0% and the 15-year survival rate was 93.3% 
according to their Kaplan–Meier analysis [34].
Carter et al. demonstrated 10-year results in 40 of his original 46 patients [35]. 
Thirty-two (80%) stated they had improvement in symptoms from the preoperative 
level. The 10 year mean IKDC score improved from the pre-op mean 50.6 (range 
32.2–68.9) to 70.1 (range 39.1–93.1). Seven patients required partial meniscectomies, 
for a 10-year graft survivorship of 83%. Of thirty-four patients with plain radio-
graphs available at the time of implantation and at 10 years for comparison, fourteen 
had no change, 15 had mild osteoarthritis, and 5 moderate to advanced progression.
Noyes et al. in his later series, 58/72 patients had follow-up at a mean of 
11.9 years ± 3.2 years [36]. Twenty-six underwent reoperation for a total graft 
survival rate of 55.2%. While demonstrating lower survivorship, their study group 
had greater chondral abnormalities and malalignment at baseline. Twenty patients 
underwent OATS procedures, and fourteen underwent an osteotomy in conjunction 
with the meniscal allograft at the time of implantation.
Van der Wal et al. reported on 63 meniscal allografts transplanted in 57 patients 
evaluated at 13.8 ± 2.8 years. Nineteen patients had grade IV chondromalacia at 
baseline, and their grafts were not secured with bone [37]. Their failure rate was 
29% (18 grafts) and twelve patients (21%) were converted to a TKR at a mean 
follow-up of 10.8 years (range 4.3–13.7). They acknowledged that the degree of 
chondromalacia, ACL deficiency, and graft fixation contributed to failures, with 
these results confirming that strict patient selection is vital for long term success.
Case studies Year Follow-up (y) Survivorship (%)
Garrett 1993 2+ 81
Noyes 2004 2+ 72
Verdonk 2006 5+ 79
Kim 2017 8+ 98
Carter 2012 10+ 83
Noyes 2016 8+ 55
Van der Waal 2009 11+ 71




Bin Medial 10+ 53
Lateral 10+ 57
Table 1. 
Selected meniscal transplant studies survivorship rates.
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Systematic reviews have emerged providing data with compiled results at 
ten-plus years after meniscal transplant implantation. Novaretti et al. combined 11 
studies with 688 meniscal allograft transplants and found a 10-year survivorship of 
73.5%, and a 15-year survivorship of 60.3% [18]. Bin et al. evaluated the long-term 
survivorship of medial versus lateral meniscal transplants at greater than ten years 
in a meta-analysis of 9 studies totaling 694 grafts, and found that 52.6% of medial 
and 56.6% of lateral grafts were intact [19].
The one study to discuss 20-year follow-up was Carter et al. where 48/56 
(86.7%) of patients were able to be contacted, and of those, had 21 required surgi-
cal treatment of the graft. Thirteen patients had an isolated partial meniscectomy. 
Eight patients had knee arthroplasty with 1 having prior partial graft removal and 
one also had a high tibial osteotomy (HTO). The average time to arthroplasty was 
12.7 years. The graft survivorship was therefore 56.2% [13].
The take-away points from the usage of meniscal transplants involve proper patient 
selection, use of a properly prepared graft, and implantation in an appropriate knee. 
When an average-weight patient without varus or valgus knee abnormalities has a 
fresh meniscal allograft placed in a stable knee without moderate or severe arthritis or 
chondral loss, the graft survival can potentially be greater than twenty years.
The data supporting meniscal scaffold implantation does not go back nearly as 
long as meniscal transplant but is also robust. Clinical studies report outcomes for 
CMI ranging up to 12 years, while the longest study on Actifit reports up to 8 years, 
both demonstrating improvements in all knee clinical outcome scales (Table 2).
For the CMI implant, Monllau et al. demonstrated 83% good and excellent 
results at 10-year follow-up for 22 patients [38]. In a randomized trial comparing 
the long-term results of patients with ACL rupture and partial medial meniscus 
defects treated with ACL reconstruction and partial medial meniscectomy versus 
medial CMI implant, Bulgheroni et al. demonstrated significant improvement of all 
clinical scores at an average of 9.6 years [39]. Also, Zaffagnini et al. showed pro-
spective study results between medial CMI implantation and partial medial men-
iscectomy [40]. The CMI group showed significantly lower VAS for pain, higher 
objective IKDC, and Tegner scores at 10-year follow-up.
The Actifit results are similarly impressive. Schuttler et al. demonstrated 
significant improvement in VAS from 5 preoperatively to 1 at 4 years of follow-up in 
a group of 18 Actifit patients [41]. Leroy et al. also showed, with a minimal follow-
up of 5 years, 15 patients improved from 5.3 and 50 preoperative VAS and subjec-
tive IKDC scores respectively to 2.9 and 79 [42]. Finally, a meta-analysis of 613 
Actifit patients demonstrated both VAS and Tegner scores improving significantly 
remaining higher up to 72 months [43]. Overall, there has been degeneration of the 
Case studies (CMI) Year Follow-up (y) Survivorship (%)
Monllau 2011 10+ 83
Bulgheroni 2015 6+ not listed
Zaffagnini 2011 10+ 88
Leroy 2017 5+ 77
(Actifit)
Schuttler 2016 2+ 100
Systematic reviews
Filardo 2015 CMI/Actifit 2+ 94
Table 2. 
Selected meniscal scaffold studies survivorship rates.
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scaffold over time with some resulting increase in osteoarthritis, with a reported 
rate of 9.9% at a mean follow-up of 40 months and 6.7% at a mean follow-up of 
44 months, for the Actifit and CMI patients, respectively [43].
The vast majority of meniscal scaffold literature has been published on medial 
implants, with a recent systematic review including 396 CMI with only 10% of them 
were implanted in the lateral compartment [44]. Zaffagnini et al. investigated 43 
patients at 24± 1.9 months after lateral CMI implant. Their Lysholm score improved 
from 64.3 ± 18.4 preoperatively to 93.2 ± 7.2 at final follow-up, with pain experienced 
during strenuous activity and at rest was significantly reduced. At 2 years of follow-
up, roughly 60% of patients reported activity levels similar to their preinjury values 
with a satisfaction rate of 95%. The presence of a higher BMI, the need for concomi-
tant procedures, and a chronic injury pattern resulted in reduced outcomes [45].
Finally, Hirschmann et al. demonstrated the results of a series of 67 patients under-
going medial or lateral CMI implantation associated with ACL reconstruction (45%), 
high tibial osteotomy (7.5%) or microfracture (4.5%). At one year the cohort demon-
strated a marked decrease in pain with a subsequent improvement in the Tegner, IKDC 
and Lysholm scores, with comparable results of the medial and the lateral groups [46].
And so, for the meniscal scaffolds, the useage and survivorship appear to be 
similar to those of the transplants; however, these implants are placed into patients 
with contained meniscal defects as opposed to the full meniscal loss which necessi-
tates the use of a meniscus transplant. When an average-weight patient without varus 
or valgus knee abnormalities has a meniscal scaffold placed in a partially debreided 
meniscus in an otherwise stable knee without moderate or severe arthritis or chondral 
loss, the graft survival can potentially be greater than ten years based on current data.
5. Conclusions
For the patient with “post-meniscectomy syndrome” with either a partially 
or entirely deficient meniscus, surgical treatment options exist which have dem-
onstrated both short, medium, and in the case of meniscus allograft, long term 
success. Allografts have demonstrated greater than 50% survivorship at 20-year 
follow-up, while scaffolds have demonstrated the progressive reabsorption with 
substitution with a meniscus-like tissue with a potential chondroprotective effect 
in shorter-term studies. For both allografts and scaffolds, patient selection and the 
treatment of concomitant knee pathology is mandatory in order to achieve both 
short and long-term clinical improvement.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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